Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation

BACKGROUND: Immune checkpoint inhibitors (ICIs) have been clinically proven to be efficient in non-small cell lung cancer (NSCLC). However, it has also been found that immunotherapy is not effective for all patients. For instance, some patients with epidermal growth factor receptor (EGFR) mutation t...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jianfeng, Zhao, Xianguang, Zhao, Kaikai, Meng, Xiangjiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495127/
https://www.ncbi.nlm.nih.gov/pubmed/34631564
http://dx.doi.org/10.3389/fonc.2021.731429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495127/
https://www.ncbi.nlm.nih.gov/pubmed/34631564
http://dx.doi.org/10.3389/fonc.2021.731429

Ejemplares similares